Just noting that Leronlimab is:

- safe and has minimal side effects
- is easy to administer
- can be administered without putting others at risk
- can be used in mono or combo with minimal drug interaction
- requires no abnormal storage temperature
- has no stability issues (no virus DNA in our MAB)
- maintains potency after months of storage
- bridges vaccine mutation shortcomings
- has multiple applications
- has manufacturer that meets stringent technical guidelines
- is pre-packaged to prevent wrong dosing
- is a medical breakthrough
- will be a ubiquitous for response to inflammation (EMT/ER/ICU)